Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

VNS Dosing Protocol: Faster Seizure Control for Epilepsy

Official title: VNS Algorithm for Advanced Dosing: Example Guided Mode Titrations "The Augusta Way"

Run by Augusta University · NCT07725601 · Data updated 2026-11-12

This trial tests a faster VNS programming method versus standard settings to see if seizures subside sooner in adults with drug-resistant epilepsy.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorAugusta University
Academic / other
Locations1 site (Augusta, Georgia)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedDecember 31, 2028
Study endsDecember 30, 2030
Registry record updatedJuly 24, 2026
Trial IDNCT07725601 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with drug-resistant epilepsy who are candidates for VNS implantation and can provide informed consent.

Probably not a fit

Patients whose seizures do not respond to VNS or who cannot complete the titration protocol may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two VNS programming paradigms in adults with epilepsy: a modified rapid titration approach called the Augusta Way and the standard titration used in routine care. Participants will have up to three visits every three months over two years, complete quality-of-life and cognitive questionnaires, and keep a seizure diary. The study aims to determine if the Augusta Way reduces seizure frequency more quickly while monitoring safety and tolerability. Results will inform clinicians about a potentially updated reference model for VNS parameter escalation in drug-resistant epilepsy. Enrollment is limited to adults eligible for VNS implantation at Augusta University and Wellstar MCG Hospital, with informed consent obtained.

Why it matters

Potential benefit: If successful, patients may experience faster seizure reduction and improved quality of life with a refined VNS dosing protocol.

How similar studies have gone: Prior VNS trials have supported individualized programming, but this specific rapid titration approach is novel and requires confirmation of safety and efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects who are clinically determined to be candidates for VNS implantation for seizure control
* Subject/legally authorized representative able to provide informed consent.

Exclusion Criteria:

* Subjects with VNS system treating pathologies other than drug refractory epilepsy or medical co-morbidities that prevent any surgical intervention

Where it's running

  • Wellstar MCG Hospital
    Augusta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AI tools to read brain MRIs in epilepsy

    Researchers are testing AI programs to help doctors read brain MRI scans in people with epilepsy to see if they can speed up diagnosis and help plan treatments.

    Recruiting at 23 sites Istituto Giannina Gaslini · Oakland, California and 22 other locations · NCT07881185

  • Alexithymia and emotional dysregulation in children with epilepsy

    This study tests how alexithymia and emotional regulation relate to epilepsy in kids aged 10–18 and compares them with healthy peers.

    Recruiting at 2 sites Istituto Giannina Gaslini · Alessandria and 1 other locations · NCT07879976

  • Decoding Mandarin speech features from brain-surface signals

    This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07460037

  • Home monitoring of seizures using a wearable EEG device for rare epilepsies

    This study is testing a new wearable device that helps people with rare types of epilepsy monitor their seizures at home to see if it can improve their treatment and care.

    Recruiting Azienda Ospedaliero-Universitaria di Modena · Roma, Italy and 3 other locations · NCT06855901

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.